Is PT-141 the same as melanotan 2?
No, though both switch on melanocortin receptors and came from related research. PT-141 (bremelanotide) is FDA approved as Vyleesi for low sexual desire that causes distress in women who have not reached menopause. Melanotan II was never approved anywhere, and Australia bans its supply. Its own research raises safety concerns that were never settled by an approval, the way PT-141's were.
Studies in people from the compound pages this answer belongs to
- PT-141
- Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials (RECONNECT) 2019 PMID 31599840
- Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder 2019 PMID 31599847
- Usefulness of ambulatory blood pressure monitoring to assess the melanocortin receptor agonist bremelanotide 2017 PMID 27977473
Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.
Part of combining and comparing peptides. Stacks, head-to-head comparisons, and what happens when nobody has tested the combination.